Easy Branches allows you to share your guest post within our network in any countries of the world to reach Global customers start sharing your stories today!

Easy Branches

34/17 Moo 3 Chao fah west Road, Phuket, Thailand, Phuket

Call: 076 367 766

info@easybranches.com

Financial Markets

Shilpa Medicare hits 52-week high on successful trial of fatty liver drug

Shilpa Medicare jumped 6.40% to Rs 741.90 after the company informed that it has successfully completed phase-3 clinical studies of its product SMLNUD07 - Nor Ursodeoxycholic Acid (NorUDCA) tablets.

By: business-standard.com

Aug 26 2024
0
0 Views

Shilpa Medicare hits 52-week high on successful trial of fatty liver drug

Shilpa Medicare hits 52-week high on successful trial of fatty liver drug

Related

Shilpa Medicare hits 52-week high on successful trial of fatty liver drug

Digital Public Infrastructure instrumental in promoting financial inclusion says RBI governor

Bajaj Housing Finance standalone net profit rises 4.51% in the June 2024 quarter

Bajaj Auto Ltd spurts 0.11%, up for fifth straight session

National Aluminium Company Ltd gains for third straight session

BJP Central Election Committee meets to finalize candidates for upcoming assembly elections

Market trade with robust gains; European mkt opens lower

Second India-Singapore ministerial roundtable kicks off in Singapore

MIC Electronics bags LoA from Northern Railway Zone

MIC Electronics receives LoA of Rs 2.54 cr from Northern Railway Zone

Volumes soar at Medplus Health Services Ltd counter

Barometers turn rangebound; realty shares advance

Digital Public Infrastructure instrumental in promoting financial inclusion says RBI governor